Aarti Pharmalabs Ltd shared its Investor Presentation for Q4 FY25, detailing company performance and metrics including 220+ products, 58 patents filed, 6 manufacturing units, and a global market share in Xanthine of 15-20%. The presentation is accessible on the company's website.